# Telomir Pharmaceuticals, Inc.: Form DEF 14A, filed Jul 28, 2026

- Company: [Telomir Pharmaceuticals, Inc.](/companies/telo.md) (CIK 1971532)
- Form: DEF 14A
- Filed: 2026-07-28
- Accepted by EDGAR: Jul 28, 2026, 17:00 ET
- Period: 2026-07-28
- Accession: 0001493152-26-035026
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1971532/000149315226035026/formdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1971532/000149315226035026/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1971532/000149315226035026/formdef14a.htm

Filed Jul 28, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-035026. Last ingested by Listed: Nov 6, 2026, 17:47 ET. No prices; not investment advice.
